A disproportion of TH1/TH2 cytokines with predominance of TH2, in urothelial carcinoma of bladder. (Q39937853)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

A disproportion of TH1/TH2 cytokines with predominance of TH2, in urothelial carcinoma of bladder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Prabhjot Singh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Nitika Badjatia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Amlesh Seth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Alpana Sharma

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

17 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

58-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

The long-term outcome in patients with superficial transitional cell carcinoma of the bladder: a single-institutional experience

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Immunologic unreactivity in bladder cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Evaluation of a test system for measuring cytokine production in human whole blood cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Type 1/Type 2 immunity in infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Development in motion: helper T cells at work

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Two types of mouse helper T-cell clone Implications for immune regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Mechanism and therapeutic reversal of immune suppression in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Chronic inflammation, immunosuppression and cancer: new insights and outlook

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Flow cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of superficial transitional cell carcinoma of bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

The three Es of cancer immunoediting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Human TH1 and TH2 subsets: doubt no more

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Lymphocyte responses and cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Strategies for use of IL-10 or its antagonists in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Analysis of type T1 and T2 cytokines in patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

The polarization of T(h)1/T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

Cytokine therapy for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.002

10.1016/J.UROLONC.2009.06.002

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837616%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference